Mast cell disorders: Protean manifestations and treatment responses.
作者信息
Chen Meng, Kim Alexander, Zuraw Bruce, Doherty Taylor A, Christiansen Sandra
机构信息
Department of Medicine, University of California San Diego, San Diego, California.
Department of Medicine, University of California San Diego, San Diego, California; Veterans Affairs, San Diego, California.
出版信息
Ann Allergy Asthma Immunol. 2018 Jul;121(1):128-130. doi: 10.1016/j.anai.2018.03.027. Epub 2018 Mar 28.
Abstract
摘要
相似文献
1
Mast cell disorders: Protean manifestations and treatment responses.肥大细胞疾病：多样的临床表现及治疗反应
Ann Allergy Asthma Immunol. 2018 Jul;121(1):128-130. doi: 10.1016/j.anai.2018.03.027. Epub 2018 Mar 28.
2
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.肥大细胞活化综合征和肥大细胞增多症：初始治疗选择和长期管理。
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1097-1106. doi: 10.1016/j.jaip.2019.02.002.
3
Mast Cell Activation Syndrome.肥大细胞活化综合征。
Clin Rev Allergy Immunol. 2018 Jun;54(3):353-365. doi: 10.1007/s12016-015-8487-6.
4
Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.遗传性α-胰蛋白酶血症在 101 例伴有过敏症状的肥大细胞激活相关症状的患者中发现，包括过敏反应。
Ann Allergy Asthma Immunol. 2021 Jun;126(6):655-660. doi: 10.1016/j.anai.2021.01.016. Epub 2021 Jan 17.
5
What are the effects of omalizumab in refractory chronic spontaneous urticaria?奥马珠单抗对难治性慢性自发性荨麻疹有哪些影响？
Medwave. 2015 Dec 24;15 Suppl 3:e6346. doi: 10.5867/medwave.2015.6346.
6
Peripheral T-cell lymphoma: a challenging mimicker of angioedema and urticaria.外周T细胞淋巴瘤：血管性水肿和荨麻疹的具有挑战性的模仿者。
Ann Allergy Asthma Immunol. 2015 Aug;115(2):94-5. doi: 10.1016/j.anai.2015.06.013.
7
[Mast cell activation syndrome].[肥大细胞活化综合征]
Hautarzt. 2013 Feb;64(2):102-6. doi: 10.1007/s00105-012-2452-6.
8
INTERACTIVE MEDICAL CASE. A Stinging Sensation.交互式医疗案例。刺痛感。
N Engl J Med. 2015 Jun 25;372(26):e35. doi: 10.1056/NEJMimc1411027.
9
Clinical characteristics in cholinergic urticaria with palpebral angioedema: Report of 15 cases.伴有睑部血管性水肿的胆碱能性荨麻疹的临床特征：15例报告
J Dermatol Sci. 2017 Feb;85(2):135-137. doi: 10.1016/j.jdermsci.2016.11.001. Epub 2016 Nov 11.
10
Adverse Reaction to Omalizumab in Patients with Chronic Urticaria: Flare Up or Ineffectiveness?慢性荨麻疹患者使用奥马珠单抗的不良反应：病情加重还是无效？
Iran J Allergy Asthma Immunol. 2016 Feb;15(1):82-6.
引用本文的文献
1
Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis.骨髓肥大细胞抗体可靶向细胞表面蛋白在系统性肥大细胞增多症中的表达谱。
Int J Mol Sci. 2019 Jan 28;20(3):552. doi: 10.3390/ijms20030552.
本文引用的文献
1
Mast cell activation syndromes.肥大细胞激活综合征。
J Allergy Clin Immunol. 2017 Aug;140(2):349-355. doi: 10.1016/j.jaci.2017.06.007.
2
Kounis syndrome: A review article on epidemiology, diagnostic findings, management and complications of allergic acute coronary syndrome.库尼斯综合征：关于过敏性急性冠状动脉综合征的流行病学、诊断结果、管理及并发症的综述文章
Int J Cardiol. 2017 Apr 1;232:1-4. doi: 10.1016/j.ijcard.2017.01.124. Epub 2017 Jan 27.
3
Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management.成人系统性肥大细胞增生症：诊断、风险分层和治疗的 2017 年更新。
Am J Hematol. 2016 Nov;91(11):1146-1159. doi: 10.1002/ajh.24553.
4
Mast Cells, Mastocytosis, and Related Disorders.肥大细胞、肥大细胞增多症及相关疾病
N Engl J Med. 2015 Jul 9;373(2):163-72. doi: 10.1056/NEJMra1409760.
5
Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab.两名系统性肥大细胞增多症患者经奥马珠单抗成功治疗后的皮肤和胃肠道症状
Case Rep Med. 2015;2015:903541. doi: 10.1155/2015/903541. Epub 2015 Jan 28.
6
Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.鉴定对伪过敏性药物反应至关重要的肥大细胞特异性受体。
Nature. 2015 Mar 12;519(7542):237-41. doi: 10.1038/nature14022. Epub 2014 Dec 17.
7
Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.肥大细胞激活综合征：通过联合检测血清胰蛋白酶和 24 小时尿 11β-前列腺素 2α 提高的识别。
J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):775-8. doi: 10.1016/j.jaip.2014.06.011. Epub 2014 Nov 6.
8
Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndrome.奥马珠单抗有效预防了一名单克隆肥大细胞活化综合征患者的复发性难治性过敏反应。
Ann Allergy Asthma Immunol. 2014 Jul;113(1):115-6. doi: 10.1016/j.anai.2014.05.001.
9
Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis.奥马珠单抗使一名患有惰性系统性肥大细胞增多症的患者的特发性过敏反应得到缓解。
Acta Derm Venereol. 2014 May;94(3):363-4. doi: 10.2340/00015555-1687.
10
Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab.使用奥马珠单抗预防与肥大细胞活化综合征相关的过敏反应。
Ann Allergy Asthma Immunol. 2012 May;108(5):383-4. doi: 10.1016/j.anai.2012.02.021. Epub 2012 Mar 21.
Zotero 插件